Resources

Proteomics Databases



Metabolomics Databases

• • How to Improve Antibody Diversity And Specificity Analysis Optimization in Research Workflows

  A decision-focused guide for immunology and antibody teams on resolving ambiguous diversity and specificity conclusions with protein-level sequence interpretation and validation planning.

• • Antigen vs Epitope: Method Selection and Research Use Cases

  Method-selection guide comparing antigen-level identification, epitope mapping, and de novo sequencing pathways for sequence-uncertain research projects.

• • How Much Does Hybridoma Sequencing Cost? Key Factors in Antibody Gene Recovery

  Researchers evaluating hybridoma sequencing often ask for a single price before hybridoma status, reporting scope, and deliverable needs are clear. That question is understandable. Grant budgets, vendor comparisons, and rescue timelines all depend on cost predictability. However, hybridoma sequencing is rarely a one-size-fits-all service.

• • Hybridoma Sequencing vs Antibody Protein Sequencing: Which Method Is More Suitable?

  Antibody sequence recovery projects often reach a fork in the road. A team may have a functional monoclonal antibody, but the available material may be hybridoma cells, RNA, purified IgG, or only a partial historical record. Hybridoma sequencing recovers VH and VL from hybridoma- derived nucleic acids. Antibody protein sequencing recovers sequence information from purified antibody protein, usually through LC-MS/MS and peptide assembly.

• • How to Perform Hybridoma Sequencing: Key Steps for Obtaining Antibody Variable Region Sequences

  Hybridoma sequencing is often requested when a monoclonal antibody is available from a hybridoma cell line, but the VH and VL sequences are missing from lab records. A culture may still produce antibody, binding assays may look acceptable, and frozen stocks may remain in storage, yet the variable-region sequences needed for recombinant expression, clone backup, or documentation were never archived.

• • Hybridoma Sequencing: Principles and Applications for Monoclonal Antibody Characterization

  Hybridoma sequencing addresses this gap by recovering antibody sequence information directly from hybridoma-derived nucleic acids. The method uses viable hybridoma cells or high-quality RNA as input, converts immunoglobulin transcripts to cDNA, amplifies variable regions by PCR, and assembles VH and VL sequences with CDR annotation.

• • Hybridoma Sequencing vs Protein-Level Antibody Sequencing: Choosing the Right Recovery Route

  The central decision is not which method is universally better. It is which method best matches the material available, the required level of evidence, and the downstream use of the recovered sequence. If your team is deciding between hybridoma cell sequencing and protein-level recovery, MtoZ Biolabs can Compare recovery routes before samples are prepared or submitted.

• • Ngs vs Sanger Sequencing: Method Selection and Research Use Cases

  A method-selection guide for researchers deciding between Sanger sequencing, NGS, and LC-MS/MS-based de novo peptide/protein sequencing.

• • Common Challenges and Strategies for Disulfide Bond Analysis

  Disulfide bonds are critical chemical linkages within the higher-order structure of proteins, playing essential roles in protein folding, stability, and function. With the rapid advancement of biopharmaceuticals and proteomics, precise characterization of disulfide bonds has become a pivotal step in high-quality protein structural analysis. Nevertheless, disulfide bond analysis in practical experiments faces several technical challenges. The following summarizes these challenges and corresponding stra......

• • 4D-DIA vs 4D-PRM: Which 4D Quantitative Approach Suits Your Project Better?

  In contemporary proteomics, Data-Independent Acquisition (DIA) and Parallel Reaction Monitoring (PRM) have emerged as two principal strategies for non-targeted and targeted protein quantification, respectively. With the integration of Ion Mobility technology, 4D proteomics on the timsTOF Pro platform incorporates the mobility dimension into the analytical framework, substantially enhancing both separation and quantification performance. Within this technological context, 4D-DIA and 4D-PRM have become ......